The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Attenuation of Murine Collagen-Induced Arthritis by a Novel, Potent, Selective Small Molecule Inhibitor of IκB Kinase 2, TPCA-1 (2-[(Aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), Occurs via Reduction of Proinflammatory Cytokines and Antigen-Induced T Cell Proliferation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Osborn, L., Kunkel, S., & Nabel, G. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2336 · Cited by 1,621
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369
How NF-κB is activated: the role of the IκB kinase (IKK) complex
Karin, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203219 · Cited by 1,156
Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene
Li, Q., Antwerp, D. V., Mercurio, F., Lee, K.-F., & Verma, I. M. (1999) · Science · doi:10.1126/science.284.5412.321 · Cited by 963
Therapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice
Tanaka, M., Fuentes, M. E., Yamaguchi, K., Durnin, M. H., Dalrymple, S. A., Hardy, K. L., & Goeddel, D. V. (1999) · Immunity · doi:10.1016/s1074-7613(00)80042-4 · Cited by 569
Collart, M. A., Belin, D., Vassalli, J. D., de Kossodo, S., & Vassalli, P. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.6.2113 · Cited by 524
Panayi, G. S., Lanchbury, J. S., & Kingsley, G. H. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350702 · Cited by 461
Makarov, S. S. (2001) · Arthritis Research · doi:10.1186/ar300 · Cited by 447
AP-1 and NF-kB Regulation in Rheumatoid Arthritis and Murine Collagen-Induced Arthritis
Han, Z., Boyle, D. L., Manning, A. M., & Firestein, G. S. (1998) · Autoimmunity · doi:10.3109/08916939808995367 · Cited by 369
Patrono, C., Patrignani, P., & Rodríguez, L. A. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13418 · Cited by 364
Collagen-induced arthritis, an animal model of autoimmunity
Myers, L. K., Rosloniec, E. F., Cremer, M. A., & Kang, A. H. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00480-3 · Cited by 316
Nuclear factor–k B in rheumatoid synovium. Localization of P50 and P65
Handel, M. L., Mcmorrow, L. B., & Gravallese, E. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381209 · Cited by 289
Kishore, N., Sommers, C., Mathialagan, S., Guzova, J., Yao, M., Hauser, S., Huynh, K., Bonar, S., Mielke, C., Albee, L., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211439200 · Cited by 272
Bozic, C. R., Gerard, N. P., von Uexkull-Guldenband, C., Kolakowski, L. F., Conklyn, M. J., Breslow, R., Showell, H. J., & Gerard, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43882-3 · Cited by 256
Inhibitor of nuclear factor ?B kinase ? is a key regulator of synovial inflammation
Tak, P. P., Gerlag, D. M., Aupperle, K. R., Geest, D. A. V. D., Overbeek, M. J., Bennett, B. L., Boyle, D. L., Manning, A. M., & Firestein, G. S. (2001) · Arthritis & Rheumatism · Cited by 234
McIntyre, K. W., Shuster, D. J., Gillooly, K. M., Dambach, D. M., Pattoli, M. A., Lu, P., Zhou, X., Qiu, Y., Zusi, F. C., & Burke, J. R. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11131 · Cited by 217
Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation
Hilliard, B. A., Mason, N., Xu, L., Sun, J., Lamhamedi-Cherradi, S.-E., Liou, H.-C., Hunter, C., & Chen, Y. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15254 · Cited by 200
Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation
Hilliard, B. A., Mason, N., Xu, L., Sun, J., Lamhamedi-Cherradi, S.-E., Liou, H.-C., Hunter, C., & Chen, Y. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215254 · Cited by 181
Feldman, M. A., Taylor, P. C., Paleolog, E. M., Brennan, F. M., & Maini, R. N. (1998) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)01365-7 · Cited by 117
Corn, R. A., Aronica, M. A., Zhang, F., Tong, Y., Stanley, S. A., Kim, S. R. A., Stephenson, L. M., Enerson, B., McCarthy, S. A., Mora, A. L., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1816 · Cited by 109
Miyazawa, K., Mori, A., Yamamoto, K., & Okudaira, H. (1998) · Europe PMC (PubMed Central) · Cited by 104
Gerlag, D. M., Ransone, L. J., Tak, P. P., Han, Z., Palanki, M. S. S., Barbosa, M. S., Boyle, D., Manning, A. M., & Firestein, G. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1652 · Cited by 97
Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors
Baxter, A., Brough, S., Cooper, A. E., Floettmann, E., Foster, S., Harding, C. J., Kettle, J. G., McInally, T., Martin, C., Mobbs, M., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.058 · Cited by 89
Essential role of T cell NF-kappa B activation in collagen-induced arthritis.
Seetharaman, R., Mora, A. L., Nabozny, G. H., Boothby, M. R., & Chen, J. (1999) · PubMed · Cited by 88
Ma, L., Qian, S., Liang, X., Wang, L., Woodward, J. E., Giannoukakis, N., Robbins, P. D., Bertera, S., Trucco, M., Fung, J. J., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1976 · Cited by 84
Essential Role of T Cell NF-κB Activation in Collagen-Induced Arthritis
Seetharaman, R., Mora, A. L., Nabozny, G. H., Boothby, M. R., & Chen, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1577 · Cited by 76
Andreakos, E., Smith, C., Monaco, C. G., Brennan, F. M., Foxwell, B. M. J., & Feldmann, M. (2003) · Blood · doi:10.1182/blood-2002-06-1835 · Cited by 65
Plaen, I. G. D., Tan, X., Chang, H., Wang, L., Remick, D. G., & Hsueh, W. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703055 · Cited by 56
The molecular basis of rheumatoid arthritis
Weyand, C. M., & Goronzy, J. J. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050167 · Cited by 56
NF-κB1 Is Required for Optimal CD4+ Th1 Cell Development and Resistance to Leishmania major
Artis, D., Speirs, K. M., Joyce, K. L., Goldschmidt, M. H., Caamaño, J., Hunter, C. A., & Scott, P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1995 · Cited by 53
Selective loss of c-Rel compromises dendritic cell activation of T lymphocytes
Boffa, D. J., Feng, B., Sharma, V. K., et al. (2003) · Cellular Immunology · doi:10.1016/s0008-8749(03)00114-x · Cited by 39
Joint destruction in rheumatoid arthritis: biological bases.
Kingsley, G. H., & Panayi, G. S. (1997) · PubMed · Cited by 28
Yoshimura, S., Bondeson, J., Brennan, F. M., Foxwell, B. M. J., & Feldmann, M. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01246.x · Cited by 28
Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation
Hilliard, B. A., Mason, N. J., Xu, L., Sun, J., Lamhamedi-Cherradi, S.-E., Liou, H., Hunter, C. A., & Chen, Y. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215254 · Cited by 19
Molecular mechanism of immune response, synovial proliferation and apoptosis in rheumatoid arthritis
Hasunuma, T., Kato, T., Kobata, T., & Nishioka, K. (1998) · Springer Seminars in Immunopathology · doi:10.1007/bf00831998 · Cited by 12
Cited by
NF-κB Signaling: Multiple Angles to Target OA
B. Marcu, K., Otero, M., Olivotto, E., Maria Borzi, R., & B. Goldring, M. (2010) · Current Drug Targets · doi:10.2174/138945010791011938 · Cited by 565
Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis
Vande Walle, L., Van Opdenbosch, N., Jacques, P., Fossoul, A., Verheugen, E., Vogel, P., Beyaert, R., Elewaut, D., Kanneganti, T.-D., van Loo, G., et al. (2014) · Nature · doi:10.1038/nature13322 · Cited by 506
Dondelinger, Y., Jouan-Lanhouet, S., Divert, T., Theatre, E., Bertin, J., Gough, P. J., Giansanti, P., Heck, A. J. R., Dejardin, E., Vandenabeele, P., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.032 · Cited by 431
“TPCA-1 was used at 5 m M, a concentration reported to inhibit both IKK a and IKK b kinase activities (IC 50 = 400 nM and 17.9 nM for IKK a and IKK b , respectively) (Podolin et al., 2005).”
InfluentialSignalling, inflammation and arthritis: NF- B and its relevance to arthritis and inflammation
Simmonds, R. E., & Foxwell, B. M. (2008) · Rheumatology · doi:10.1093/rheumatology/kem298 · Cited by 381
Yang, H., Zhang, W., Pan, H., Feldser, H. G., Lainez, E., Miller, C., Leung, S., Zhong, Z., Zhao, H., Sweitzer, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046364 · Cited by 377
Metadata
- Authors
- Podolin, P. L., Callahan, J. F., Bolognese, B. J., Li, Y. H., Carlson, K., Davis, T. G., Mellor, G. W., Evans, C., & Roshak, A. K.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 312
- Issue
- 1
- Pages
- 373-381
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2112785503
- Cited by
- 298
- References
- 41
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.